“…To date, >100 different Cx26 mutations have been described, with new variants being continually discovered. − Different genetic disorders or variants produce varying phenotypes. − For example, the truncated variant 35delG induces the complete loss of the connexin function, , whereas, in the presence of the M1V, P173R, and R184P mutations, Cx26 protein is not produced. , Furthermore, connexins with M34T, L90P, R127H, or F161S do not function or are not correctly transported and incorporated into the cell membrane despite their high expression levels. , There are two possible effects of Cx26 mutations: the misfolding and removal of the protein or its incorporation into the plasma membrane in the inactive form. − Similar phenomena were described in cystic fibrosis transmembrane conductance regulator (CFTR), and other proteins have been developed to restore those functionalities. − The functional hemichannel properties of wild-type (WT) Cx26 have been characterized via voltage clamp experiments, single-channel analyses, molecular dynamic analyses, Raman measurements, and cell-based microarray experiments. − Studies have reported that Cx26 mutations affect its hemichannel activity and are thermosensitive. , In a previous study, we used HeLa cells as an expression system for WT Cx26 and its mutated forms to investigate the channel function of WT Cx26 and mutants R127H, R184P, and F161S …”